Biosynex SA (FR:ALBIO) has released an update. Biosynex’s subsidiary, Chembio Diagnostics, has received a $1.5 million grant from the Bill & Melinda Gates Foundation to develop a rapid diagnostic test ...
STRASBOURG, France, March 29, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced that ...
Feb 16 (Reuters) - Biosynex SA : * Obtains CE mark for rapid serological test new generation of infection by HIV 1 and 2 responsible for AIDS (Exacto Pro Test HIV) Source text: bit.ly/215UZVd Further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results